The Shared Cellular Mechanism Driving Sanfilippo Syndrome and Alzheimer's Disease

A groundbreaking study from UC San Diego has identified a shared cellular mechanism driving brain degeneration in two seemingly unrelated diseases: Sanfilippo syndrome type A (a rare childhood dementia) and Alzheimer's disease. The research, published August 11, 2026 in Immunity, reveals that a family of proteins acting as master genetic switches in the brain's immune cells may be the key to understanding—and eventually treating—both conditions .

The Shared Cellular Mechanism: Lysosomal Waste Buildup in Microglia

The researchers discovered that lysosomal waste buildup inside microglia—the brain's resident immune cells—triggers a maladaptive genetic response that drives neurodegeneration in both Sanfilippo syndrome type A (MPS IIIA) and Alzheimer's disease .

In Sanfilippo syndrome type A, a single gene variant blocks production of the enzyme sulfamidase, causing cellular debris to accumulate in lysosomes. While waste builds up in many cell types, microglia are the most severely impacted: they expand and become clogged with fats and proteins, losing their ability to protect neurons .

MITF/TFE Proteins as Master Genetic Switches

The study identified the MITF/TFE family of proteins as master genetic switches in microglia . When lysosomes become overburdened and stressed, these switches flip from "off" to "on," triggering a massive reprogramming of microglial gene expression. This response is initially intended to protect the brain, but it eventually becomes maladaptive, fueling inflammation and contributing to neuronal death .

The research provided evidence for "dominant and context-dependent roles of members of the MITF/TFE family as major drivers of microglia-specific epigenetic and transcriptional changes resulting from lysosomal stress" . Critically, the same MITF/TFE switches were found activated in microglia from human Alzheimer's patients, confirming the molecular overlap between these two conditions .

Inside-Out Versus Outside-In Neurodegeneration

This discovery reframes the fundamental direction of neurodegeneration. Many researchers previously believed that extracellular amyloid plaques cause lysosomal failure from the "outside in" . The UC San Diego team showed instead that damage can originate directly from inside the cell—lysosomal dysfunction alone is sufficient to trigger neurodegeneration, as demonstrated by the clear-cut genetic cause in MPS IIIA .

This supports an "inside-out" model in which intracellular lysosomal failure is a primary driver of disease, not merely a downstream consequence of extracellular pathology.

New Treatment Strategies: Targeting the Lysosomal Program

The findings suggest a fundamental shift in drug development strategy. Most current microglia-targeted drugs focus on cell-surface receptors. The researchers propose instead targeting the intracellular lysosomal program . By modulating MITF/TFE genetic switches, scientists may be able to maintain microglia in a protective state and prevent them from damaging the brain.

The team also found that microglia attempt to minimize damage early in the disease before becoming overwhelmed, pointing to the importance of early intervention .